Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

In a study published in Cell Reports Physical Science on Nov. 25, a research team reported the development of an innovative ...

Nov. 18, 2024 — An international team of researchers has achieved an unprecedented milestone: the creation of mouse stem cells capable of generating a fully developed mouse using genetic tools ...

Pyxis Oncology (NASDAQ:PYXS) is down ~38% in after-hours trading Wednesday after posting preliminary phase 1 data on PYX-201, ...

Immune cells thereby contribute to the crosstalk between the microbiota and the brain ... You already have the perfect ...

Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...

So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the microenvironment is too tumor-friendly. ... Researchers Make ...

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

Event: 4 th Annual BTIG Ophthalmology Day Participant: Dr. Gary S. Jacob, CEO of OKYO Pharma For more information about the ...

SABCS® “Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM – 8:30 AM CST highlights positive BriaCell survival and ...